Joseph S. Shan
2012
In 2012, Joseph S. Shan earned a total compensation of $569.7K as Vice President, Clinical & Regulatory Affairs at Peregrine Pharmaceuticals.
Compensation breakdown
| Bonus | $6,000 |
|---|---|
| Non-Equity Incentive Plan | $136,500 |
| Option Awards | $133,512 |
| Salary | $259,808 |
| Other | $33,888 |
| Total | $569,708 |
Shan received $259.8K in salary, accounting for 46% of the total pay in 2012.
Shan also received $6K in bonus, $136.5K in non-equity incentive plan, $133.5K in option awards and $33.9K in other compensation.
Rankings
In 2012, Joseph S. Shan's compensation ranked 8,330th out of 11,487 executives tracked by ExecPay. In other words, Shan earned more than 27.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,330 out of 11,487 | 28th |
Division Manufacturing | 3,020 out of 4,253 | 29th |
Major group Chemicals And Allied Products | 804 out of 1,198 | 33rd |
Industry group Drugs | 579 out of 920 | 37th |
Industry Pharmaceutical Preparations | 452 out of 700 | 35th |
Source: SEC filing on August 28, 2014.
Shan's colleagues
We found four more compensation records of executives who worked with Joseph S. Shan at Peregrine Pharmaceuticals in 2012.
2012
Steven King
Peregrine Pharmaceuticals
Chief Executive Officer
2012
Jeffrey Masten
Peregrine Pharmaceuticals
Former Vice President, Quality
2012
Paul Lytle
Peregrine Pharmaceuticals
Chief Financial Officer
2012
Shelley Fussey
Peregrine Pharmaceuticals